Skip to content
Lower risk Medical device recall · FDA · Published July 18, 2018

Abbott ARCHITECT Creatine Kinase Recall: Stability Error Risk

Abbott recalls ARCHITECT Creatine Kinase IVD with potential stability issues causing error codes and QC failures. Affected units include specific lot numbers and expiration dates.

🇺🇸 FDA recall #Z-1076-2019Medical deviceAbbott ›
Take action

Contact the company

Recalling firmAbbott Laboratories, Inc1921 Hurd Dr · Irving, TX 75038-4313
✎ GovInfoNow plain-language explainer

Abbott is recalling its ARCHITECT Creatine Kin:ase IVD test kit due to stability problems that might cause error messages or inaccurate quality control results. This could lead to incorrect test outcomes if the device is used without proper calibration. Read more at govinfonow.com/recall/70421-abbott-architect-creatine-kinase-recall-stability-error-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/70421-abbott-architect-creatine-kinase-recall-stability-error-risk · Updated August 20, 2026 · FDA enforcement record: FDA #Z-1076-2019

Cite this page

“Abbott ARCHITECT Creatine Kinase Recall: Stability Error Risk.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/70421-abbott-architect-creatine-kinase-recall-stability-error-risk. Based on FDA recall #Z-1076-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1076-2019%22&limit=1).

The FDA announced on July 18, 2018, that Abbott Laboratories, Inc. voluntarily recalled its ARCHITECT Creatine Kinase IVD kits due to a stability issue. The hazard may cause error codes or out-of-range quality control results.

How to tell if you have it

  • Brand: Abbott
  • Product: ARCHITECT Creatine Kinase, IVD, REF 7D6341
  • UPC: 00380740101176
  • Lot number: 99633UN18
  • Expiration date: 02JAN19
  • Quantity: 30 kits

The hazard

According to the FDA, the product has a stability issue which may lead to an error code indicating "Unable to calculate result, reaction check failure" and/or Quality Control results out of range low.

Context

GovInfoNow's records show Abbott Laboratories, Inc. has 11 other recalls on record since Sept. 29, 2017. Other recent recalls of similar products include the Abbott Alinity s System Software Version 2.8.0 Recall (Feb. 3, 2022), the Abbott Alinity s System Recall (July 12, 2021), and the Abbott ARCHITECT C System Mixer Recall (May 1, 2019). Other recent recalls of similar products include the Siemens Dimension Creatinine Flex Reagent Cartridge Recall (March 18, 2026), the Abbott ID NOW Influenza A & B 2 Kit recall (Feb. 9, 2026), and the Biomerieux VITEK 2 AST-N461 Test Kit Recall (July 24, 2026).

How to tell if you have this one

Check for the lot number 99633UN18 with expiration date 02JAN19 on the product label. The unique device identifier (UDI) starts with (01)00380740101176(17)190102(10).

  • Brand
    Abbott
  • Product
    Abbott ARCHITECT Creatine Kinase, IVD, REF 7D6341
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Distribution was made nationwide, including Puerto Rico. There was also government and military distribution. Foreign distribution was made to Algeria, Argentina, Australia, Austria, Belarus, Belgium, Bermuda, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Ecuador, Egypt, El Salvador, Estonia, Finland, France, Gaza & Jericho, Germany, Greece, Guatemala, Hong Kong, Hungary, India, Indonesia, Iraq, Ireland, Israel, Italy, Jamaica, Kazakhstan, Kuwait, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Macedonia, Malaysia, Maldives, Mali, Mexico, Moldova, Morocco, Netherlands, Netherlands (Curacao), New Zealand, Norway, Oman, Pakistan, Paraguay, Philippines, Poland, Portugal, Qatar, Republic of Yemen, Romania, Russia, Rwanda, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Tanzania, Thailand, Trinidad & Tobago, Tunisia, Turkey, UAE, Uganda, United Kingdom, Uruguay, Vietnam, and Zimbabwe.
Recall numberProduct, codes & lotsQuantity
Z-1075-2019Abbott ARCHITECT Creatine Kinase, IVD, REF 7D63-21.; Lot number 87697UN18, exp. 22OCT18; UDI (01)00380740012878 (17)181022(10)87697UN18; Lot number 99632UN18, exp. 12NOV18, UDI (01)00380740012878 (17)181112(10)99632UN18; and Lot 24358UN18, exp. 05DEC18, UDI (01)00380740012878 (17)181205(10)24358UN18.6,187 kits kits
Z-1076-2019Abbott ARCHITECT Creatine Kinase, IVD, REF 7D6341.; Lot number 99633UN18, exp. 02JAN19, UDI (01)00380740101176(17)190102(10)99633UN18.30 kits
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the lot number 99633UN18 and expiration date 02JAN19 on the device label.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Distribution was made nationwide, including Puerto Rico. There was also government and military distribution. Foreign distribution was made to Algeria, Argentina, Australia, Austria, Belarus, Belgium, Bermuda, Bosnia and Herzegovina,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2.1 years after the firm started it.

1. Firm started the recall: Jul 18, 201812. FDA classified it Class II: Mar 30, 201923. Published in FDA’s Enforcement Report: Apr 10, 201934. FDA terminated the recall: Aug 13, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1076-2019 (July 18, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1076-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA